Imperial Valley News
Rome, Italy - We affirm our full support for the Libyan people in maintaining the unity of Libya and its institutions that function for the benefit of the whole Country. A Government of National Accord based in the capital Tripoli is urgently needed to provide Libya the means to maintain governance, promote stability and economic development.
Dallas, Texas - Women with Type 2 diabetes are twice as likely to have coronary heart disease compared to men, and may also need more frequent and intense physical activity to lower their risk of having a heart attack or stroke, according to a new American Heart Association scientific statement published in the association’s journal Circulation.
Atlanta, Georgia - A new report calls attention to cancer in people with mental illness, suggesting that healthcare system and societal factors are just as critical as individual lifestyle factors linked to smoking and obesity, that lead to health disparities among this group. The report appears early online in CA: A Cancer Journal for Clinicians.
San Antonio, Texas - Among patients with HER2-positive, metastatic breast cancer that had progressed despite treatment with two or more forms of HER2-targeted therapy (trastuzumab [Herceptin] and lapatinib [Tykerb]), median overall survival was increased for those treated with trastuzumab emtansine (T-DM1 [Kadcyla]) compared with those who received treatment of physician’s choice, according to results from the phase III TH3RESA clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held December 8–12.
San Antonio, Texas - Among patients with early-stage breast cancer, those who received breast- conserving surgery plus radiation therapy had improved overall survival after 10 years compared with those who received mastectomy without radiation therapy, according to data presented at the 2015 San Antonio Breast Cancer Symposium, held December 8–12.
Washington, DC - The U.S. Food and Drug Administration cleared for marketing in the United States the first cooling cap to reduce hair loss (alopecia) in female breast cancer patients undergoing chemotherapy.